JP2012502071A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012502071A5 JP2012502071A5 JP2011526411A JP2011526411A JP2012502071A5 JP 2012502071 A5 JP2012502071 A5 JP 2012502071A5 JP 2011526411 A JP2011526411 A JP 2011526411A JP 2011526411 A JP2011526411 A JP 2011526411A JP 2012502071 A5 JP2012502071 A5 JP 2012502071A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- formulated
- composition according
- peptide
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08016142.5 | 2008-09-12 | ||
| EP08016142A EP2163259B1 (en) | 2008-09-12 | 2008-09-12 | Use of an Ang-(1-7) receptor agonist in acute lung injury |
| PCT/EP2009/006619 WO2010028845A2 (en) | 2008-09-12 | 2009-09-11 | Use of an ang-(1-7) receptor agonist in acute lung injury |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013257932A Division JP5881122B2 (ja) | 2008-09-12 | 2013-12-13 | 急性肺損傷におけるang−(1−7)レセプターアゴニストの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012502071A JP2012502071A (ja) | 2012-01-26 |
| JP2012502071A5 true JP2012502071A5 (cg-RX-API-DMAC7.html) | 2013-05-16 |
Family
ID=40430691
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011526411A Pending JP2012502071A (ja) | 2008-09-12 | 2009-09-11 | 急性肺損傷におけるang−(1−7)レセプターアゴニストの使用 |
| JP2013257932A Expired - Fee Related JP5881122B2 (ja) | 2008-09-12 | 2013-12-13 | 急性肺損傷におけるang−(1−7)レセプターアゴニストの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013257932A Expired - Fee Related JP5881122B2 (ja) | 2008-09-12 | 2013-12-13 | 急性肺損傷におけるang−(1−7)レセプターアゴニストの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (4) | US20110281805A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2163259B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2012502071A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20110074978A (cg-RX-API-DMAC7.html) |
| CN (2) | CN103263661A (cg-RX-API-DMAC7.html) |
| BR (2) | BR122013002187A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2736922C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2393455T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010028845A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2393455T3 (es) * | 2008-09-12 | 2012-12-21 | Charité-Universitátsmedizin Berlin (Charité) | Uso de un agonista del receptor Ang-(1-7) en lesiones pulmonares agudas |
| JP2015504870A (ja) * | 2011-12-16 | 2015-02-16 | タリックス ファーマシューティカルズ リミテッド | 線維症を処置するためのアンジオテンシン |
| CN102532265A (zh) * | 2011-12-29 | 2012-07-04 | 中国人民解放军第四军医大学 | 一种短肽、其异构体及其应用 |
| US20130210726A1 (en) * | 2012-02-10 | 2013-08-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of peripheral vascular disease |
| US8557958B1 (en) | 2012-06-18 | 2013-10-15 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of diabetes |
| CA2884792A1 (en) * | 2012-09-17 | 2014-03-20 | Tarix Pharmaceuticals Ltd. | Oral formulations of angiotensin |
| US8633158B1 (en) * | 2012-10-02 | 2014-01-21 | Tarix Pharmaceuticals Ltd. | Angiotensin in treating brain conditions |
| CN105636645A (zh) * | 2013-04-19 | 2016-06-01 | 爱荷华大学研究基金会 | 在肌萎缩症中的血管紧张素 |
| JP2016520592A (ja) * | 2013-05-24 | 2016-07-14 | タリックス ファーマシューティカルズ リミテッド | マルファン症候群および関連障害の処置におけるアンジオテンシンペプチド |
| WO2015054005A1 (en) * | 2013-10-11 | 2015-04-16 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of bdnf-related conditions |
| US9333233B2 (en) | 2014-02-25 | 2016-05-10 | Tarix Pharmaceuticals Ltd. | Methods and compositions for the delayed treatment of stroke |
| RU2016152088A (ru) * | 2014-07-17 | 2018-08-21 | Юниверсити Оф Саузерн Калифорния | Способы, соединения и композиции для лечения заболеваний опорно-двигательного аппарата |
| CN106535920B (zh) | 2014-07-21 | 2020-10-30 | 代表亚利桑那大学的亚利桑那校董会 | Ang-(1-7)衍生物寡肽及其使用和生产方法 |
| US10183055B2 (en) * | 2014-07-21 | 2019-01-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications |
| JP7010698B2 (ja) * | 2015-04-08 | 2022-01-26 | コーニンクレッカ フィリップス エヌ ヴェ | 急性呼吸促迫症候群(ards)のリスクスコアによって導かれる換気治療推薦のためのツール |
| WO2018129511A2 (en) * | 2017-01-09 | 2018-07-12 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Ang-(1-7) and derivative oligopeptides for the treatment of traumatic brain injury and other cognitive impairments |
| US20200188473A1 (en) * | 2017-05-02 | 2020-06-18 | Beth Israel Deaconess Medical Center, Inc. | Combination therapy for cancer |
| CN112316107B (zh) * | 2019-07-17 | 2023-01-06 | 首都医科大学附属北京妇产医院 | 血管紧张素(1-7)在胰腺疾病中的应用 |
| WO2021183863A1 (en) * | 2020-03-13 | 2021-09-16 | Constant Therapeutics Llc | Methods and compositions for treatment of coronavirus infection |
| WO2022094025A1 (en) * | 2020-10-30 | 2022-05-05 | Gere Dizerega | Angiotensin-1-7 for the treatment of covid-19 |
| US12343331B2 (en) | 2021-01-28 | 2025-07-01 | Capacity Bio, Inc. | Methods and agents that stimulate mitochondrial turnover for treating disease |
| EP4085921A1 (en) | 2021-05-04 | 2022-11-09 | CU-Pharmaceuticals UG | Angiotensin-(1-7) in the treatment of sars-cov related diseases |
| CN117147877A (zh) * | 2023-08-30 | 2023-12-01 | 重庆医科大学附属儿童医院 | Ang1-7作为生物标志物在预测、诊断儿童脓毒症中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6110895A (en) * | 1996-12-16 | 2000-08-29 | University Of Southern California | Method of promoting healing in skin grafts |
| YU78601A (sh) | 1999-05-05 | 2005-07-19 | Aventis Pharma Deutschland Gmbh. | 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže |
| AU2003217783A1 (en) * | 2002-02-27 | 2003-09-09 | Wake Forest University | Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth |
| US20050119180A1 (en) * | 2002-03-28 | 2005-06-02 | Roks Antonius J.M. | Use of angiotensin 1-7 for enhancing cardiac function |
| EP1723962A1 (en) * | 2005-05-19 | 2006-11-22 | IMBA-Institut für Molekulare Biotechnologie GmbH | Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries |
| BRPI0503122A (pt) | 2005-05-30 | 2007-05-02 | Univ Minas Gerais | composições farmacêuticas do peptìdeo angiotensina-(1-7) [ang-(1-7)] e seus análogos, agonistas e antagonistas usando as ciclodextrinas, seus derivados, e o polìmeros biodegradáveis e/ou dos produtos derivados para uso no controle das funções do sistema reprodutivo |
| BRPI0502497A (pt) | 2005-06-28 | 2007-02-06 | Univ Minas Gerais | uso de agonistas e antagonistas do receptor acoplado a proteìna g, mas, como moduladores de atividade apoptótica para o estudo, a prevenção e o tratamento de doenças |
| BRPI0602366B1 (pt) | 2006-04-26 | 2017-12-12 | Universidade Federal De Minas Gerais | Use of agonists of the receptor coupled to protein g, but, in the treatment of metabolic syndrome, its components and their complications |
| WO2008130217A1 (en) * | 2006-08-08 | 2008-10-30 | Applied Nanosystems B.V. | Cyclic angiotensin analogs |
| ES2393455T3 (es) * | 2008-09-12 | 2012-12-21 | Charité-Universitátsmedizin Berlin (Charité) | Uso de un agonista del receptor Ang-(1-7) en lesiones pulmonares agudas |
-
2008
- 2008-09-12 ES ES08016142T patent/ES2393455T3/es active Active
- 2008-09-12 EP EP08016142A patent/EP2163259B1/en not_active Not-in-force
-
2009
- 2009-09-11 WO PCT/EP2009/006619 patent/WO2010028845A2/en not_active Ceased
- 2009-09-11 CN CN2013101168734A patent/CN103263661A/zh active Pending
- 2009-09-11 BR BR122013002187A patent/BR122013002187A2/pt not_active IP Right Cessation
- 2009-09-11 BR BRPI0918443A patent/BRPI0918443A2/pt not_active IP Right Cessation
- 2009-09-11 KR KR1020117008209A patent/KR20110074978A/ko not_active Ceased
- 2009-09-11 CN CN200980135629.4A patent/CN102164614B/zh not_active Expired - Fee Related
- 2009-09-11 US US13/063,685 patent/US20110281805A1/en not_active Abandoned
- 2009-09-11 JP JP2011526411A patent/JP2012502071A/ja active Pending
- 2009-09-11 EP EP09778494A patent/EP2341938A2/en not_active Ceased
- 2009-09-11 CA CA2736922A patent/CA2736922C/en not_active Expired - Fee Related
-
2012
- 2012-08-21 US US13/590,894 patent/US8383772B2/en not_active Expired - Fee Related
-
2013
- 2013-06-28 US US13/931,168 patent/US20140073760A1/en not_active Abandoned
- 2013-12-13 JP JP2013257932A patent/JP5881122B2/ja not_active Expired - Fee Related
-
2015
- 2015-06-25 US US14/750,500 patent/US20160051621A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010001839A (es) | Metodo y aparato para comunicacion y metodo y aparato para controlar comunicacion. | |
| WO2011080102A3 (en) | Glp-1 analogues and derivatives | |
| AU2007295179A1 (en) | Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances | |
| JP2005524658A5 (cg-RX-API-DMAC7.html) | ||
| JP2009102342A5 (cg-RX-API-DMAC7.html) | ||
| JP2010504343A5 (cg-RX-API-DMAC7.html) | ||
| WO2009006095A3 (en) | Dual portion lozenge dosage form | |
| AR075148A1 (es) | Formulacion de rasagilina de liberacion retardada. proceso para fabricar citrato de rasagilina | |
| JP2008533007A5 (cg-RX-API-DMAC7.html) | ||
| JP2009535352A5 (cg-RX-API-DMAC7.html) | ||
| MY155402A (en) | Pharmaceutical composition of a potent hcv inhibitor for oral administration | |
| WO2008069917A3 (en) | Novel cyclic peptides | |
| JP2013542247A5 (cg-RX-API-DMAC7.html) | ||
| NZ597858A (en) | Vaccines and compositions against streptococcus pneumoniae | |
| JP2010536889A5 (cg-RX-API-DMAC7.html) | ||
| WO2009043926A3 (en) | Oral fast disintegrating tablets | |
| CY1127230T1 (el) | Φαρμακευτικη συνθεση για απο του στοματος χορηγηση περιλαμβανουσα κρυσταλλικα αλατα του αμιδιου (4s,4as,5ar,12as)-4-διμεθυλαμινο- 3,10,12,12α-τετραϋδροξυ-7-[(μεθοξυ(μεθυλ)αμινο)- μεθυλ]-1,11 -διοξο 1,4,4α,5,5α,6,11,12α-οκταϋδρο- ναφθακενο-2-καρβοξυλικου οξεος | |
| JP2010511663A5 (cg-RX-API-DMAC7.html) | ||
| NZ597488A (en) | Pharmaceutical for oral delivery comprising mgbg and methods of treating disease | |
| JP2023071670A5 (cg-RX-API-DMAC7.html) | ||
| NZ600583A (en) | Visfatin therapeutic agents for the treatment of acne and other conditions | |
| WO2010082220A3 (en) | Sustained release pharmaceutical composition of quetiapine and process for preparation thereof | |
| JP2011528897A5 (cg-RX-API-DMAC7.html) | ||
| PH12013500173A1 (en) | Oral controlled release pharmaceutical compositions of blonanserin | |
| WO2007095661A8 (en) | Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |